Abstract
This project aims to study castration-resistant prostate cancer (CRPC) cells from DU-145 (isolated from brain metastasis) and PC-3 (isolated from bone metastasis) cell lines when treated with porcine heparin, specifically analyzing the expression of hepcidin, the iron-regulating hormone, and heparanase. CRPC, being resistant to androgen deprivation hormonal treatment, has a higher chance …